Rchr
J-GLOBAL ID:201601018703859097   Update date: Jun. 05, 2024

RYUTARO MORI

RYUTARO MORI
Affiliation and department:
Research field  (1): Tumor diagnostics and therapeutics
Research theme for competitive and other funds  (2):
  • 2019 - 2022 The study for the mechanism of 5FU-resistance based on the metabolism of 5FU inbreast cancer cells
  • 2016 - 2019 数理情報解析システムを用いたドラッグ・リポジショニングによる5-FU耐性機序解明
Papers (43):
  • Nobuhisa Matsuhashi, Hiroyuki Tomita, Hidenori Tanaka, Yoshinori Iwata, Satoshi Matsui, Hisashi Imai, Masahiro Fukada, Chika Mizutani, Takao Takahashi, Itaru Yasufuku, et al. Evaluation of histopathological heterogeneity of colorectal cancer liver metastasis sites after preoperative chemotherapy. Molecular and clinical oncology. 2022. 16. 3. 61-61
  • Takeharu Imai, Yoshihiro Tanaka, Yuta Sato, Junichi Mase, Tomonari Suetsugu, Masahiro Fukada, Itaru Yasufuku, Yoshinori Iwata, Ryutaro Mori, Hisashi Imai, et al. The Role of Adjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma Patients with Pathological Positive Lymph Nodes After Neoadjuvant Chemotherapy Followed by Esophagectomy: a Single Institute Retrospective Analysis. Indian journal of surgical oncology. 2021. 1-9
  • Chiemi Saigo, Yusuke Kito, Masayoshi Hasegawa, Shusuke Nomura, Takuya Mikamo, Yuki Hanamatsu, Ryutaro Mori, Manabu Futamura, Kazuhiro Yoshida, Tamotsu Takeuchi. Incidental cytokeratin-positive interstitial reticulum cell tumor of the lymph node accompanied by breast cancer: Status of YAP/TAZ expression in tumor cells. Human Pathology: Case Reports. 2021. 200526-200526
  • Tomonari Suetsugu, Ryutaro Mori, Manabu Futamura, Masahiro Fukada, Hideharu Tanaka, Itaru Yasufuku, Yuta Sato, Yoshinori Iwata, Takeharu Imai, Hisashi Imai, et al. Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines. Oncology reports. 2021. 45. 4
  • Manabu Futamura, Yoshihisa Tokumaru, Kazuaki Takabe, Hirofumi Arakawa, Yoshimi Asano, Ryutaro Mori, Junichi Mase, Akira Nakakami, Kazuhiro Yoshida. MIEAP, a p53-downstream gene, is associated with suppression of breast cancer cell proliferation and better survival. American journal of cancer research. 2021. 11. 12. 6060-6073
more...
MISC (9):
more...
Books (2):
  • DCISの診断と治療-最新動向-2治療編、 DCISの薬物療法(ホルモン&分子標的)
    2012
  • 術後化学療法、乳癌、具体的なレジメンと, 施行の実際-ホルモン療法
    2012
Education (1):
  • - 2013 Gifu University Graduate School of Medicine
Professional career (1):
  • 医学博士
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page